Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery
- 22 November 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 138 (2), 255-259
- https://doi.org/10.1007/s00432-011-1085-y
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- The Survival Impact of the Intergroup 0116 Trial on Patients With Gastric CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Adjuvant Therapy for Resected Gastric Cancer—Rapid, Yet Incomplete Adoption Following Results of Intergroup 0116 TrialInternational Journal of Radiation Oncology*Biology*Physics, 2008
- The impact of radiotherapy on survival in resectable gastric carcinoma: A meta-analysis of literature dataCancer Treatment Reviews, 2007
- Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniquesThe British Journal of Radiology, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomachInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Status of extended lymph node dissection: Locoregional control is the only way to survive gastric cancerJournal of Surgical Oncology, 2005
- Perspectives in the treatment of gastric cancerNature Clinical Practice Oncology, 2005
- Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's viewBritish Journal of Cancer, 2004